12 Oct 2023 07:00
Tristel plc
("Tristel" or the "Company")
Â
Additional Investor Presentation
Â
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that the Company will deliver a Company Overview presentation at a hybrid event in London hosted by the UK Individual Shareholders' Society (ShareSoc) on Thursday 19 October 2023 and available to ShareSoc members via the link below:
Â
https://www.sharesoc.org/sharesoc-walbrook-pr-healthcare-companies-hybrid-event-london-19-october-2023-5pm/
Â
Paul Swinney, Chief Executive Officer will deliver an "in-person" presentation which will also be streamed live (and recorded), allowing ShareSoc members to watch virtually.
Â
Preliminary results for the year ended 30 June 2023 will be announced on Monday 16 October 2023 and no new material information will be disclosed in the presentation.
Â
As previously announced the Company will also provide both an online presentation and in-person presentation open to all interested investors on Monday 16 October 2023. Further details can be found here:
https://tristelgroup.com/wp-content/uploads/2023/09/TSTL-Notice-of-results-FINAL.pdf
Â
Â
Â
For further information please contact:
Â
Tristel plc | Tel: 01638 721 500 | |
Paul Swinney, Chief Executive Officer | ||
Liz Dixon, Chief Financial Officer | ||
 | ||
Walbrook PR Ltd | Tel: 020 7933 8780 or tristel@walbrookpr.com | |
Paul McManus | Mob: 07980 541 893 | |
Lianne Applegarth | Mob: 07584 391 303 | |
Charlotte Edgar | Mob: 07884 664 686 | |
Cavendish Capital Markets Limited | Tel: 020 7220 0500 | |
Geoff Nash/Charlie Beeson (Corporate Finance) | ||
Sunila de Silva (ECM) | ||
Â
Â